Blueprint Medicines Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting Sustained Clinical Benefits of AYVAKIT ®/AYVAKYT ® (avapritinib) May 31, 2024 Comments are off
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 31, 2024 Comments are off
Is This the Beginning of a Trend Reversal? Watch These Indicators for Clues May 31, 2024 Comments are off
Gold Falls as US Dollar Strengthens; Euro Slumps on German Inflation Data May 31, 2024 Comments are off